Dose Finding Study of MCI-186 in Acute Ischemic Stroke
| 대상 질환 | Acute Ischemic Stroke |
|---|---|
| 임상 단계 | 2상 |
| 스폰서 | Shionogi |
| 상태 | 조기 종료 |
| 참여자 수 | 17 명 |
| 중재(약물) | Continuous infusion high-dose MCI-186, Continuous infusion low-dose MCI-186, Continuous infusion placebo, Approved dosing regimen MCI-186, Approved dosing regimen placebo |
| 시작일 | 2017년 11월 17일 |
| 완료일 | 2018년 5월 14일 |
| 결과 공개일 | 2025년 1월 9일 |
요약
To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.
Number of Participants With National Institutes of Health Stroke Scale (NIHSS) Score Improved.
| Continuous Infusion High-dose Group (Group H) | 0 Participants |
|---|---|
| Continuous Infusion Low-dose Group (Group L) | 0 Participants |
| Approved Dosing Regimen Group (Control Group) | 0 Participants |
| Continuous Infusion High-dose Group (Group H) | 2 Participants |
| Continuous Infusion Low-dose Group (Group L) | 0 Participants |
| Approved Dosing Regimen Group (Control Group) | 1 Participants |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain — Prasad Shirvalkar, MD, PhD
- Women's Health Initiative Strong and Healthy Study — Fred Hutchinson Cancer Center
- Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke — Shionogi
- Zambia Stroke Unit Study — Johns Hopkins University
- Tracking Post-stroke Walking Improvements From the Clinic Into the Home — Western University of Health Sciences
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University